Chevron
Go back
Alnylam Pharmaceuticals logo

Alnylam Pharmaceuticals

Since December 31, 2001
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
Icon, Cambridge, United States
Cambridge, United States
Icon, 1001 — 5000 employees
1001 — 5000 employees
Icon, Raised $2.23B
Raised $2.23B
Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
Post-IPO Debt
September 13, 2022
$900M
See all investors and rounds